Notable Analyst Rating Changes 11/14: CLX, LDK, ALO, URBN Upgraded; GSK, EMR, LHO, UDR Downgraded
More News related to ALO
- Does CV Therapeutics (CVTX) Have A Case of Merger-Cockiness?
- Top 15 For 2008 (No. 14): M&A Wreckage
- King Pharmaceuticals (KG) Completes Acquisition of Alpharma
- S&P Announces Changes to US Indices: IRM for UST, FSP for ALO
- Notable Analyst Rating Changes 12/03: LMT, DRI, CTAS Upgraded; ALO, SYK, FSLR Downgraded
More News related to CLX
- Dividend Increases At Record Low, Dividend Cuts Highest In Over 50 Years
- Clorox Announces Aug. 3, 2009, Webcast of Fourth-Quarter and Fiscal Year 2009 Results
- Deutsche Bank Maintains a 'Hold' Rating on Clorox (CLX); Raises Price Target
- Sara Lee Corp. (SLE) Says No To Private-Equity Shops (Blackstone, KKR)
- David Moenning's Daily State of the Markets: 6/15
More News related to EMR
- Emerson Survey Shows Global Economic Downturn Not Slowing Pursuit of Data Center Energy Efficiency
- Emerson Joins ZigBee Alliance Board of Directors
- China Ritar Power Corp. Experiencing an Increase in Demand for Lead Acid Batteries
- Emerson Wins Major Automation Contract for Biopharmaceutical Plant in Singapore
- Emerson (EMR) Declares Qtr. Dividend of $0.33/Share, Yielding 3.58%
UPGRADES:
Goldman Sachs upgrades Clorox Co. (NYSE: CLX) from Sell to Neutral
Morgan Stanley upgrades LDK Solar (NYSE: LDK) from Equal Weight to Overweight, but trimmed their price target from $42 to $23.
Cowen & Co upgrades Alpharma (NYSE: ALO) from Neutral to Outperform.
Stifel Nicolaus upgrades Urban Outfitters (Nasdaq: URBN) from Hold to Buy.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
UBS downgrades GlaxoSmithKline (NYSE: GSK) from Buy to Neutral.
J.P. Morgan downgrades Emerson (NYSE: EMR) from Neutral to Underweight.
BB&T and JMS Securities downgraded LaSalle Hotel Properties (NYSE: LHO) to Hold and Neutral, respectively.
BMO Capital downgrades UDR Inc. (NYSE: UDR) from Outperform to Market Perform.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Morgan Keegan initiates coverage on Nokia (NYSE: NOK) with a Market Perform.
Morgan Keegan initiates coverage on Garmin (Nasdaq: GRMN) with a Market Perform.
Banc of America initiated coverage on Schering-Plough (NYSE: SGP) and Pfizer (NYSE: PFE) with Buy ratings today.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+0.00
-29.15Related Entities
- Stifel Nicolaus
- UBS
- JPMorgan
- Goldman Sachs
- Morgan Stanley
- Banc of America
- BMO Capital
- BB&T Capital Markets
- Morgan Keegan & Company
- Notable Analyst Rating Changes
- Cowen & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
